TrialClinical epigenetics2019

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.

Cornelis M van Tilburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.